quote:

---

Originally posted by WinsumLosesum:
MONDAY, JULY 19, 2004
Independent Study Shows Lifestream Technologies' Cholesterol Monitor to Be as Accurate as Physician's Office Test; Consumers Can Trust Home Test Results  - BusinessWire 6:30 AM  

POST FALLS, Idaho, Jul 19, 2004 (BUSINESS WIRE) -- Lifestream Technologies, Inc. (LFTC), the leading manufacturer of home cholesterol monitors and professional screening devices, today announced that an independent accuracy and precision study was conducted by Radiant Research, Inc., comparing the Lifestream Cholesterol Monitor against three professional methods: a physician's office lab system, a local independent lab, and the Abell-Kendall method, the US government accuracy and precision standard for all cholesterol test devices.

"It is extremely important that we determine accuracy of at-home testing," stated Dr. Michael Davidson, Medical Director for Radiant Research. "At-home testing provides an opportunity for patients to assume more control of their overall health. If patients can identify the problem early on, they can work with their physician to initiate treatment."

This independent study was conducted at Radiant's Tucson, Arizona, facility under strict scientific controls with trial protocol approved by an Institutional Review Board. The study assessed Lifestream's home cholesterol monitor against an independent lab, a popular physician's office lab system, and the CDC-controlled standard, the Abell-Kendall technique, at a Cholesterol Reference Method Lab. A copy of the study results are available on Lifestream's website at http://www.knowitforlife.com/proresources.asp or by email at gerriv@lifestreamtech.com.

"This study was motivated by recent articles, which implied that results provided by home cholesterol test devices were inaccurate," stated Christopher Maus, Lifestream's President and CEO. "These articles' conclusions, based on non-scientific testing procedures, were assumptive at best and conducted in a casual manner leading the reader to an erroneous conclusion. This journalist approach misleads the public. Although we don't believe any particular media group would intentionally utilize what, in scientific circles, would be considered "junk science," we are trying to reassure the public as to what pure science says about Lifestream's product. The Radiant Research study's conclusions proved that test results obtained with Lifestream's cholesterol monitor were as accurate and precise as the results obtained from a physician's office or an independent lab."

The National Cholesterol Education Program (NCEP) has concluded that home testing can be an important tool in improving adherence to cholesterol programs. Separate studies indicate that as few as 30% of patients remain on statin medication after one year. Home testing has proven to be effective in monitoring blood pressure and glucose; now, it is also effective in cholesterol management programs.

"The results of this preliminary study are clear and unambiguous," stated Jackson Connolly, Lifestream's VP Product Development. "Under strict scientific evaluation protocols and lab practices, the Lifestream Cholesterol Monitor's results prove as accurate as test results received from a physician's office. To further confirm this, a number of other universities are preparing to replicate this study to confirm the results. It is expected that the results of this expanded study will encourage the media to use good journalistic practices relying on scientific literature rather than relying on misleading outcomes from nonscientific methods. We expect the expanded study results to be submitted to important peer review journals."

About Radiant Research

Based near Seattle, Radiant Research (http://www.radiantresearch.com) is a comprehensive clinical research company that provides Phase I-IV clinical drug development services to the biopharmaceutical and medical device industry. Radiant is comprised of more than 50 wholly owned premier clinical research sites nationwide, employing over 1,000 research professionals exclusively focused on providing professional, high-quality comprehensive clinical research services. In the past four years, Radiant has conducted more than 8,400 clinical trials across 18 therapeutic specialties. Radiant's client list includes every major pharmaceutical company and contract research organization and many biotechnology and medical device companies.

About Lifestream Technologies

The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.

The Company's product line aids the health-conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.

Lifestream's monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) Personal Health Card(R) allowing multiple users the ability to store their personal results. Lifestream's products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream's products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.

---

quote:

---

Originally posted by Leardron:
Anybody know when they will submit their 2nd Qtr results?

---

Lifestream Announces RxSchool's Launch of National Pharmacy Education Program; Continuing Education Program Focuses on Increasing Patient Adherence Through Home Monitoring

POST FALLS, Idaho--(BUSINESS WIRE)--July 27, 2004--Lifestream Technologies, Inc. (OTCBB:LFTC), the leading manufacturer of home cholesterol monitors and professional screening devices, today announced that RxSchool is releasing a new pharmacy continuing education program designed to provide pharmacists with a greater understanding of the role home cholesterol monitoring plays in helping patients manage their cholesterol levels and improve overall patient compliance.

Steve Croke, President of RxSchool, stated, "Those patients on cholesterol-lowering drugs rarely stay on them long enough to derive the cardiovascular benefits the therapy can provide. The science is clear that one effective method is for patients to get regular feedback from self monitoring. To educate the pharmacist on this science is key to making a change in adherence. This is one of our best CE programs yet, and we are very excited about being able to provide pharmacists with an opportunity to adopt new tools in their effort to control heart disease."

"With only 30% of patients remaining on statin drugs after the first year, the value of improving patient adherence is undeniable," said Christopher Maus, Lifestream's President and CEO. "Statin drugs, considered by many to be extremely important for Americans' cardiovascular health, is the largest drug sector, exceeding $17 billion a year. Monitoring cholesterol at home is a proven method for enhancing patient adherence. It is very important that pharmacists understand the nature and value of patient self monitoring."

"We are very pleased that RxSchool, one the nation's premier providers for continuing education, has elected to provide this educational campaign for cholesterol management," stated Ed Siemens, Lifestream's COO. "These efforts will provide pharmacists throughout the U.S. with additional knowledge to support their patients in managing cholesterol through home monitoring. The role of home monitoring in the continuum of care is growing in importance. We are pleased that pharmacists, 120,000 strong, will have such a valuable educational resource."

About RxSchool.com

A division of Pharmacy Choice, Inc., RxSchool is an e-learning web portal and software solutions company that provides a comprehensive suite of educational courses and training tools for the health care industry. The RxSchool website is utilized by tens of thousands of pharmacists, pharmacy technicians, physicians and nurses who practice in hospital, retail, managed care, long-term care, private practice and various other health care settings. As a leader in educational solutions for the industry, RxSchool is supported by pharmaceutical industry sponsors and endorsed by industry associations, employers and educational institutions. For more information about RxSchool or Pharmacy Choice, please visit their respective web sites at www.rxschool.com or www.pharmacychoice.com

About Lifestream Technologies

The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.

The Company's product line aids the health-conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader, further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.

POST FALLS, Idaho, Sep 9, 2004 (BUSINESS WIRE) -- Lifestream Technologies, Inc. (LFTC), the leading supplier of cholesterol monitors and professional screening instruments, announced that the Lifestream Cholesterol Monitor with Health Risk Assessment (HRA) will be sold exclusively on a national shopping network over the next two months.

"Due to our previous success, we have been selected to present our newest product in monthly airings on one of television's major shopping networks. With the network's distribution exceeding 80 million homes, this is a unique opportunity to continue to build category awareness and increase revenues," said Christopher Maus, Lifestream's President and CEO. "Our Cholesterol Monitor with Health Risk Assessment (HRA) brings new meaning to individuals seeking to take control of their heart health. Along with cholesterol results, numerous factors related to heart health are assessed giving individuals a clear and meaningful outcome of personal choices and changes that can be made to improve a person's level of health."

"Lifestream obtained a 510(k) clearance to market its new technology from the FDA this past June," stated Jack Connolly, VP Product Development. "This revolutionary technology enables individuals to not only track cholesterol levels, but to calculate their personal risk of heart attack, obesity, etc. After taking a three-minute cholesterol test, you only need to input a few additional risk factors, including gender, age, height, weight, diabetic status, smoker/non-smoker, systolic and diastolic blood pressure, and HDL breakout from a recent lipid profile. The HRA shows the user's risk of a heart attack. In addition, the monitor allows the user to evaluate different outcome models by altering the inputs (i.e., smoker vs. non-smoker), which supports an individual's efforts to change in a comprehensive way."

About Lifestream Technologies

The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.

The Company's product line aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.

POST FALLS, Idaho, Sep 27, 2004 (BUSINESS WIRE) -- Lifestream Technologies, Inc. (LFTC), the leading supplier of cholesterol monitors and professional screening instruments, announced that the U.S. Court of Appeals for the Federal Circuit has reversed an adverse District Court decision against Lifestream and remanded it back to the District Court for further proceedings.

Lifestream asserted that a test strip being marketed by Polymer Technology Systems, Inc., which performed measurements of HDL cholesterol, infringed a patent owned by Lifestream. The U.S. District Court for the District of Idaho had ruled that Polymer's test strips did not infringe that patent. The Court of Appeals reversed the District Court's ruling in Lifestream's favor and remanded the matter back to the District Court.

"We are pleased the Court of Appeals overturned the District Court decision. We believe that our HDL patent has significant value," stated Lifestream's President and CEO, Christopher Maus. "In an effort to bring this matter to a conclusion, we have entered into a Letter of Intent with Polymer to come to an agreement to resolve this matter through a licensing arrangement and provide adequate protection of Lifestream's proprietary rights. Ending this costly litigation will allow us to better focus our resources on developing and expanding product awareness."

About Lifestream Technologies

The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.

The Company's product line aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.

Lifestream's monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) Personal Health Card(R) allowing multiple users the ability to store their personal results. Lifestream's products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream's products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.

Cholesterol has become one of the Top major issues in America.

quote:

---

Originally posted by pharmdman:
I can attest that these are starting to sell from the pharmacy shelves (at least where I work). They're not flying off the shelves, but slowly selling. However, that's much better than just sitting there like they've been doing.

---

quote:

---

Originally posted by WinsumLosesum:
Well, in light of your recent and current weather woes, NOT flying off the shelves could be considered a good thing. How ya holdin' up in the Windy State, pharm?

---

POST FALLS, Idaho, Sep 30, 2004 (BUSINESS WIRE) -- Lifestream Technologies, Inc. (LFTC), the leading supplier of cholesterol monitors and professional screening instruments, announced today that its shipments for the month of July are up 169% over the same period in 2003. Preliminary numbers indicate $581,486 shipped during July 2004 as compared to $216,052 for the previous July.

"It appears that our increased distribution, acceptance by the viewers of the television shopping network and other marketing efforts are increasing awareness and impacting demand at the retail shelf," said Christopher Maus, President and CEO. "These shipment numbers indicate the Company is on target as we begin the next phase of our rollout strategy. Our new Health Risk Assessment product, which began limited rollout in September, will further aid the health conscious consumer in creating a healthier lifestyle. Lifestream continues to grow the market with expanded distribution. We will continue our efforts to increase product awareness and support our retailers as we now have what can be truly considered national distribution."

"This increase in shipments is a good indicator of our success in increasing distribution and creating awareness," stated Nikki Nessan, VP, Finance. "However, Lifestream's revenue recognition policy does not necessarily result in revenue recognition at the time product is shipped. As a result, shipments are not an indicator of the revenue to be reported on our financial statements."

About Lifestream Technologies

The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.

The Company's product line aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.

quote:

---

Originally posted by Leardron:

I thought with Walgreens carrying their monitor's now and their increased advertising on the radio that it would start selling better. They had even announced a 29% increase in sales about a month ago. Guess I will have to wait for their 10Q for last quarter.

---

I can tell you this. The monitor has a high price tag.

With other types of monitors, there are rebates and coupons that cycle every few weeks that allow the user to purchase the monitor essentially free or extremely discounted. The real money is made on selling the strips anyway. For instance, most of the blood glucose monitors sell for around $70, but you can get them between $0-$20 during rebates and coupons. The Lifestream has a $3 coupon for a $119 monitor. Most people are waiting for the "real rebates and coupons" to begin. Also, the replacement strips are $20 for 6 strips. That's a bit pricey also.

However, that having been said, I've started to see some movement on the monitor and the strips in recent weeks.

One other point: CVS also carries this monitor. As they convert the newly purchase Eckerd stores, they'll need to purchase more monitors and strips from Lifestream just to stock those stores. Perhaps that will boost the numbers a little too.

POST FALLS, Idaho, Oct 6, 2004 (BUSINESS WIRE) -- Lifestream Technologies, Inc. (LFTC), the leading supplier of cholesterol monitors and professional screening instruments, announced today that its Cholesterol Monitor with Health Risk Assessment (HRA) was posted as the best selling item in Healthy Living Aids during the 24-hour period in which it was presented.

"Because of this great response, Lifestream's product will air again in October. If our product continues to do well, Lifestream would like to pursue a more regular schedule after the holiday season," said Christopher Maus, Lifestream's president and CEO. "With the network's distribution exceeding 80 million homes, the opportunity to present on a more regular basis would continue to build awareness of our product and increase revenues. Since our new HRA product is being sold exclusively on this network, the Company has a great opportunity to get its marketing message out prior to rolling out to other classes of trades."

Lifestream obtained a 510(k) clearance for its new technology from the FDA this past June. This technology enables individuals to not only track cholesterol levels, but to calculate their personal risk of heart attack. After taking a three-minute cholesterol test, the user need only input a few additional risk factors, including gender, age, height, weight, diabetic status, smoker/non-smoker, systolic and diastolic blood pressure, and HDL breakout from a recent lipid profile. The HRA shows the user's risk of a heart attack. In addition, the monitor allows the user to evaluate different outcome models by altering the inputs (i.e., smoker vs. non-smoker), which supports and individuals efforts in a compressive way."

About Lifestream Technologies

The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.

The Company's product line aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.

POST FALLS, Idaho, Oct 13, 2004 (BUSINESS WIRE) -- Lifestream Technologies, Inc. (OTCBB:LFTC), the leading supplier of cholesterol monitors and professional screening instruments, announced today that its shipments for the month of August were up 124% over the same period in 2003. Preliminary numbers indicate $429,141 of product shipped during August 2004, as compared to $191,766 for the previous August.

"We believe disclosure of these monthly shipment numbers addresses investor questions and are indicative of our broad-based efforts, particularly in marketing," said Christopher Maus, President and CEO. "Since the shipment change is so apparent, we thought it appropriate to convey that number prior to the end of the quarter. It appears our increased distribution, acceptance by the television shopping network's viewers, and other marketing efforts are having an impact on our retailers. Shipment numbers indicate the retailer is either increasing inventory or increasing sell-through at the retail shelf, which moves the medical device category in the right direction."

Lifestream's revenue recognition policy does not necessarily result in revenue recognition at the time product is shipped. As a result, shipments are not an indicator of the revenue to be reported on our financial statements.

About Lifestream Technologies

The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.

The Company's product line aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.

POST FALLS, Idaho, Oct 21, 2004 (BUSINESS WIRE) -- Lifestream Technologies, Inc. (OTCBB:LFTC), the leading supplier of cholesterol monitors, announced today that preliminary numbers indicate shipments for the first quarter of FY2005 increased 108% over shipments for the first quarter of FY2004.

"We see the increase in shipment numbers as a move by our customers to build inventory and to cover retail sales. September shipment numbers are indicative of our broad-based efforts, particularly in marketing and increased distribution," said Christopher Maus, President and CEO. "It appears our increased distribution, acceptance by the television-shopping network's viewers, and other marketing efforts are having an impact on our retailers. Shipment numbers indicate the retailer is either increasing inventory or supporting sell-through."

Lifestream's revenue recognition policy does not necessarily result in revenue recognition at the time product is shipped. As a result, shipments are not an indicator of the revenue to be reported on the financial statements.

About Lifestream Technologies

The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.

The Company's product line aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.

Lifestream Technologies Ranked 40th Fastest Growing Technology Company in North America on the 2004 Deloitte Technology Fast 500

Lifestream is rated in the top 50 out of 500 companies

POST FALLS, Idaho, Nov 4, 2004 (BUSINESS WIRE) -- Lifestream Technologies, Inc. (LFTC), the leading supplier of cholesterol monitors, announced today that it ranked Number 40 on the 2004 Deloitte Technology Fast 500, a ranking of the 500 fastest growing technology companies in North America. Rankings are based on a percentage of revenue growth over five years from 1999-2003. Lifestream's revenues grew 6,846% during this period.

"Achieving sustained revenue growth of 6,846% over five years is a tremendous accomplishment during a difficult period for the technology sector," said Mark A. Evans, national managing partner of Deloitte's Technology, Media & Telecommunications Group. "Lifestream's phenomenal growth puts it in select company."

Lifestream's CEO, Christopher Maus, credits the introduction of its cholesterol monitor to the consumer market and increased retail presence with the Company's 6,846% revenue growth over the past five years. "We are honored to be rated so high on the Deloitte Technology Fast 500," stated Maus. "Our success has been driven by consumers taking more responsibility for their heart health. We look forward to continuing revenue growth by increasing distribution channels and building consumer awareness for our product."

Fast 500 Selection and Qualification

The Fast 500 list is compiled from Deloitte's 19 regional North American Fast 50 programs, nominations submitted directly to the Fast 500, and public company database research. Winners are selected based on the percentage of growth in revenues from 1999 to 2003. To be considered, Fast 500 entrants must have had 1999 operating revenues of at least $50,000 USD and $75,000 CD for the United States and Canada, respectively; and 2003 operating revenues must be at least $1 million USD or CD.

Entrants must also be public or private companies headquartered in North America and must be a "technology company," defined as a company that owns proprietary technology that contributes to a significant portion of the company's operating revenues or devotes a significant proportion of revenues to the research and development of technology. Using other companies' technology in a unique way does not qualify.

About Lifestream Technologies

The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.

The Company's product line aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.

Lifestream's monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) Personal Health Card(R) allowing multiple users the ability to store their personal results. Lifestream's products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream's products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.

About Deloitte

Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, its member firms and their respective subsidiaries and affiliates. As a Swiss Verein (association), neither Deloitte Touche Tohmatsu nor any of its member firms has any liability for each other's acts or omissions. Each of the member firms is a separate and independent legal entity operating under the names "Deloitte," "Deloitte & Touche," "Deloitte Touche Tohmatsu," or other related names. Services are provided by the member firms or their subsidiaries or affiliates and not by the Deloitte Touche Tohmatsu Verein.